ZIKV treatment of GL261 gliomas also resulted in increased recruitment of Ly6C+ monocytes (31-fold), F4/80+ macrophages (~15-fold), and CD11b+ monocyte-derived DCs (~8-fold) (Figure 2A). This evidence concerns the gene ITGAM and central nervous system cancer.